Lab7 Systems

The company said it will use the proceeds to further develop its core software platform, and to hire additional programmers and bioinformaticians.

Their combined offering will provide customers with a single solution for managing lab operations and performing sequence analysis and mutation identification.  

Lab7 Systems has released a beta version of its next-generation sequencing data workflow management software platform, available for download to early-access users from the company's website. The company is planning updates to the software every four to six weeks.

Lab7 Systems has launched a beta version of its next-generation DNA sequence data workflow management software platform. The company is seeking feedback from beta users that will further development of its software which is expected to launch fully later this year.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.